Avia Pharma – is a nordic pharmaceutical company & was founded by a group of senior executives. Avia Pharma will grow significantly through both acquisitions and in licensing of products. We strive to create value for all stakeholders, owners, customers and the society. We are a fast growing and innovative company with a robust and sustainable business model. Our goal – is to become the market leader in selected therapeutic areas with prescription and otc products.
2017-12-20: License agreement signed for Vectavir, Vectatone and Silence
2018-01-15: Parents prepared to pay out of pocket for D vitamin without palm oil
2018-02-01: Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology
2018-02-05: Long term license agreement signed for Intrarosa